PUBLISHER: Grand View Research | PRODUCT CODE: 2017754
PUBLISHER: Grand View Research | PRODUCT CODE: 2017754
The global laboratory animal medicine market size was estimated at USD 7.2 billion in 2025 and is projected to reach USD 11.5 billion by 2033, growing at a CAGR of 6.1% from 2026 to 2033. The market growth is driven by the intensification of precision medicine & humanized model demand, rising burden of chronic disease research, integration of AI and digital health monitoring, and global health security & zoonotic surveillance.
The rising global burden of chronic conditions, specifically oncology, neurodegenerative diseases, and metabolic disorders, serves as a primary catalyst for the laboratory animal medicine sector. Unlike acute toxicity studies, chronic disease research necessitates longitudinal protocols that extend animal lifespans within a facility. This prolonged duration directly correlates with an increased requirement for sustained medical management and health monitoring. For instance, in oncology, the use of immunocompromised and humanized mouse models requires stringent diagnostics & health surveillance products. These animals are highly susceptible to opportunistic infections, driving the continuous use of serology & PCR test kits to maintain colony biosecurity and microbiology & parasitology assays to ensure pathogen-free status. Furthermore, the complexity of tumor progression studies mandates high-frequency clinical chemistry & hematology reagents/panels to monitor systemic physiological changes and organ function over time.
The demand for therapeutics & preventive medicines is similarly intensified by chronic modeling. Longitudinal studies for arthritis or cardiovascular diseases require long-term administration of analgesics & sedatives and anti-inflammatory & supportive care drugs to meet welfare standards and manage pain without compromising study data. Moreover, clinical care devices & equipment such as infusion & syringe pumps and ventilators & respiratory support systems are critical for the precise, metered delivery of experimental compounds and the maintenance of animal health during invasive procedures over several months.
Advanced chronic disease modeling also relies heavily on clinical imaging & diagnostic devices and animal patient monitoring devices to track disease markers non-invasively. As research institutions transition from short-term trials to multi-month chronic observations, the consumption of clinical & welfare consumables such as needles, syringes, catheters & vascular access sets, and bandages, wound care & surgical consumables increases. This shift from volume-based testing to high-value, long-term health management ensures a stable revenue market trajectory, as every additional day an animal remains in a study necessitates a corresponding unit of medical support, preventive care, and diagnostic oversight.
Global Laboratory Animal Medicine Market Report Segmentation
This report forecasts revenue growth at the regional and country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global laboratory animal medicine market based on product, animal model, application, customer, and region: